WA

Walpar Nutritions LtdNSE WALPAR Stock Report

Last reporting period 30 Sep, 2021

Updated 18 Sep, 2024

Last price

Market cap $B

0.002

Micro

Exchange

XNSE - National Stock Exchange Of India

WALPAR.NS Stock Analysis

WA

Uncovered

Walpar Nutritions Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.002

Dividend yield

Shares outstanding

4.7 B

Walpar Nutritions Ltd is a IN-based company operating in Personal Care Products industry. The company is headquartered in Kalol, Gujarat. The company went IPO on 2021-07-13. Walpar Nutritions Ltd is an India-based nutraceutical, pharmaceutical and healthcare company. The firm is engaged in manufacturing various types of nutraceutical formulation, pharmaceutical ingredients, and pharmaceuticals formulation. The company has vertically integrated Herbo nutraceutical products manufacturing facilities in western parts of India, Gujarat. Its portfolio includes tablets, capsules, powder/sachets, and oral liquids. The company manufactures various private label/third party brands to different companies across the country and overseas. Its products include Pcos Care Forte, Procive-F, Procive-M, Proplus, BIOMID, FERROF, FTM-plus, FTW-plus, G-Flora INOSIA-F, Joint-CR, NI-1000, Ortin-5, Ova-Wom, PCOS-CARE, Refitil-F, Refitil-M, Seagut, Spinac, TRIVITA, flaxseed- Oil, Ironica-CR, Magorich, PDF, PIYO, and Ashyuka Plus. The company has its own platform for trading of nutraceutical, herbal, ayurvedic and pharmaceutical raw materials.

View Section: Eyestock Rating